摘要
炎性小体是一类由凋亡相关微粒蛋白、半胱天冬酶(caspase)及NOD样受体组成的多蛋白复合物,它能介导caspase-1活化,促进炎症因子白细胞介素(IL)-1β和IL-18前体成熟。该文主要介绍急性冠脉综合征与炎性小体相关性的研究进展。
出处
《国际心血管病杂志》
2014年第6期365-367,共3页
International Journal of Cardiovascular Disease
基金
国家自然科学基金(81303075)
参考文献32
-
1Hwang I.)S,Shin ES, Kim SJ,et al. Early differentialchanges in coronary plaque composition according to plaquestability following statin initiation in acute coronarysyndrome: classification and analysis by intravascularultrasound-virtual histology [J]. Yonsei Med J,2013,54(2): 336-344.
-
2Zamani P, Schwartz GG,Olsson AG, et al. Inflammatorybiomarkers,death, and recurrent nonfatal coronary eventsafter an acute coronary syndrome in the MIRACL study [J],J Am Heart Assoc,2013y 2(1): e003103.
-
3Takahashi M. Role of the inflammasome in myocardial infarction[J]. Trends Cardiovasc Med* 2011,21(2):37-41.
-
4Artlett CM. The Role of the NLRP3 Inflammasome inFibrosis[j]. Open Rheumatol J,2012,6:80-86.
-
5Duewell P,Kono H, Rayner KJ, et al. NLRP3 inflammasomes arerequired for atherogenesis and activated by cholesterolcrystals[j]. Nature,2010,464(7293) : 1357-1361.
-
6Kim SR,Kim DI, Kim SH, et al. NLRP3 inflammasomeactivation by mitochondrial ROS in bronchial epithelial cellsis required for allergic inflammation [ J ]. Cell Death Dis,2014,5:el498.
-
7Libby P. Inflammation in atherosclerosis[J]. Nature, 2002,420(6917): 868-874.
-
8Weber C, Soehnlein O. ApoE controls the interface linkinglipids and inflammation in atherosclerosis[J]. J Clin Invest,2011,121(10):3825-3B27.
-
9Witztum JL, Lichtman AH. Theinfluence of innate andadaptive immune responses on atherosclerosisCJj. Annu RevPathol,2014,9:73-102.
-
10Satoh M, Ishikawa Y,Minami Y,et al. Role of Toll likereceptor signaling pathway in ischemic coronary arterydisease[J]. Front Biosci,2008,13.. 6708-6715.
同被引文献31
-
1廖玉华.心血管疾病免疫学研究进展[J].郑州大学学报(医学版),2005,40(2):181-183. 被引量:11
-
2Shao BZ, Xu ZQ, Han BZ, et al. NLRP3 inflammasome and its inhibitors: a review[J]. Front Pharmaeol, 2015, 6: 262.
-
3Garg NJ. Inflammasomes in cardiovascular diseases [ J ]. Am J Cardiovasc Dis, 2011, 1(1) : 244 -254.
-
4Till S, Jorge HM, Eran E, et al. Inflammasomes in health and disease[ J]. Nature, 2012, 481 (7381) : 278 - 286.
-
5Bauernfeind F, Hornung V. Of inflammasomes and pathogens- sensing of microbes by the inflammasome [ J ]. Embo Molecular Medicine, 2013, 5(6): 814-826.
-
6Haneklaus M, O'Neill LA, Coil RC. Modulatory mechanisms con- trolling the NLRP3 inflammasome in inflammation: recent develop- ments[J]. Curr Opin Immunol, 2013, 25( 1 ) : 40 -45.
-
7Martinon F, Burns K, Tschopp J. The inflammasome: a molecular platform triggering activation of inflammatory caspases and process- ing of proIL-β[J]. Mol Cell, 2002, 10(2) : 417 -426.
-
8Rajamaki K, Lappalainen J, O6mi K, et al. Cholesterol crystals activate the NLRP3 inflammasome in human macrophages: a novel link between cholesterol metabolism and inflammation [ J ]. PLoS One, 2010, 5(7) : 1 -9.
-
9Grebe A, Latz E. Cholesterol Crystals and Inflammation[ J ]. Curt Rheumatol Rep, 2013, 15(3) : 313.
-
10Sabine Steffens, Francois Mach. Inflammation and Atherosclerosis [J]. Herz, 2004, 29(8) : 741 -748.
-
1王位,马远方,韩根成.NLRW3炎性小体激活调控机制研究新进展[J].国际免疫学杂志,2015,38(4):343-347. 被引量:11
-
2汪青园,刘忠,陀泳华,王进山,石忠松.猪颈动脉粥样硬化斑块易损性与Nod样受体家族包含pyrin结构域蛋白3炎性小体的关系[J].中华实验外科杂志,2016,33(5):1187-1189. 被引量:3
-
3魏祺,程晓曙.NLRP3炎性小体研究进展[J].基础医学与临床,2015,35(1):117-121. 被引量:15
-
4黄燕华,华檬,崔学范.芍药苷减弱真菌葡聚糖诱导的支气管上皮细胞内NLRP3炎性小体活化[J].南京医科大学学报(自然科学版),2017,37(3):287-292. 被引量:5
-
5余小慧.炎性体:caspase-1的活化平台并参与调节免疫应答及疾病的发病机制[J].中国病理生理杂志,2009,25(7):1414-1414.
-
6付丽瑶,周伏喜,王学红,卢放根.游离脂肪酸对THP-1巨噬细胞NALP3炎性通路的影响[J].中南大学学报(医学版),2014,39(8):811-817. 被引量:3
-
7王晓宇,王秋月.NLRP3炎性小体与糖尿病肾病相关性研究进展[J].医学研究杂志,2015,44(5):180-182. 被引量:3
-
8罗彩云,丁家望,郑霞霞,周天.NLRP3炎性小体、胆固醇结晶与动脉粥样硬化关系的研究进展[J].海南医学,2016,27(11):1837-1839. 被引量:4
-
9董元宝,尹丽娟,李伟真,王英华,王小龙.外周血单核细胞表达Nod样受体蛋白炎症小体与冠状动脉病变程度的相关性[J].中国慢性病预防与控制,2015,23(5):347-349. 被引量:1
-
10甘祥海,吕湛.NLRP3炎性小体在动脉粥样硬化发生发展中的作用[J].临床与病理杂志,2015,35(3):462-468. 被引量:8